These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27034244)

  • 1. The Impact of Different DCE-Based Approaches When Anchoring Utility Scores.
    Norman R; Mulhern B; Viney R
    Pharmacoeconomics; 2016 Aug; 34(8):805-14. PubMed ID: 27034244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values.
    Shah KK; Ramos-Goñi JM; Kreimeier S; Devlin NJ
    Eur J Health Econ; 2020 Sep; 21(7):1091-1103. PubMed ID: 32506281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.
    Norman R; Cronin P; Viney R
    Appl Health Econ Health Policy; 2013 Jun; 11(3):287-98. PubMed ID: 23649892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
    Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
    Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences.
    Mulhern B; Bansback N; Hole AR; Tsuchiya A
    Med Decis Making; 2017 Apr; 37(3):285-297. PubMed ID: 27681988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of a Discrete Choice Experiment Including Both Duration and Dead for the Development of an EQ-5D-5L Value Set for Australia.
    Norman R; Mulhern B; Lancsar E; Lorgelly P; Ratcliffe J; Street D; Viney R
    Pharmacoeconomics; 2023 Apr; 41(4):427-438. PubMed ID: 36720793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?
    Augestad LA; Rand K; Luo N; Barra M
    Value Health; 2020 Apr; 23(4):487-494. PubMed ID: 32327166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data.
    Ramos-Goñi JM; Oppe M; Estévez-Carrillo A; Rivero-Arias O;
    Value Health; 2022 May; 25(5):835-843. PubMed ID: 35500952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dealing with the health state 'dead' when using discrete choice experiments to obtain values for EQ-5D-5L heath states.
    Ramos-Goñi JM; Rivero-Arias O; Errea M; Stolk EA; Herdman M; Cabasés JM
    Eur J Health Econ; 2013 Jul; 14 Suppl 1(Suppl 1):S33-42. PubMed ID: 23900663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a discrete choice experiment to estimate health state utility values.
    Bansback N; Brazier J; Tsuchiya A; Anis A
    J Health Econ; 2012 Jan; 31(1):306-18. PubMed ID: 22197308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.
    Robinson A; Spencer A; Moffatt P
    Med Decis Making; 2015 Apr; 35(3):341-50. PubMed ID: 25349189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How different are composite and traditional TTO valuations of severe EQ-5D-5L states?
    Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA
    Qual Life Res; 2016 Aug; 25(8):2101-8. PubMed ID: 26875190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Australian discrete choice experiment to value eq-5d health states.
    Viney R; Norman R; Brazier J; Cronin P; King MT; Ratcliffe J; Street D
    Health Econ; 2014 Jun; 23(6):729-42. PubMed ID: 23765787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the relative value of health and social care related quality of life using a discrete choice experiment.
    Mulhern B; Norman R; De Abreu Lourenco R; Malley J; Street D; Viney R
    Soc Sci Med; 2019 Jul; 233():28-37. PubMed ID: 31153085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of Time Trade-Off and Discrete Choice Experiments.
    Augustovski F; Belizán M; Gibbons L; Reyes N; Stolk E; Craig BM; Tejada RA
    Value Health; 2020 Jul; 23(7):880-888. PubMed ID: 32762989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Differences between TTO and DCE in the Valuation of Health States.
    Robinson A; Spencer AE; Pinto-Prades JL; Covey JA
    Med Decis Making; 2017 Apr; 37(3):273-284. PubMed ID: 27646566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating health state utility values from discrete choice experiments--a QALY space model approach.
    Gu Y; Norman R; Viney R
    Health Econ; 2014 Sep; 23(9):1098-114. PubMed ID: 24943827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.